169,029 Shares in Anteris Technologies Global Corp. $AVR Bought by Marex Group plc

Marex Group plc purchased a new stake in shares of Anteris Technologies Global Corp. (NASDAQ:AVR) during the 2nd quarter, HoldingsChannel reports. The firm purchased 169,029 shares of the company’s stock, valued at approximately $641,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. acquired a new position in shares of Anteris Technologies Global in the first quarter worth about $130,000. Deutsche Bank AG acquired a new stake in shares of Anteris Technologies Global during the 1st quarter valued at about $59,000. Invesco Ltd. purchased a new position in shares of Anteris Technologies Global in the 1st quarter valued at about $149,000. Nuveen LLC acquired a new position in Anteris Technologies Global in the 1st quarter worth about $71,000. Finally, Corebridge Financial Inc. acquired a new position in Anteris Technologies Global in the 1st quarter worth about $27,000.

Anteris Technologies Global Stock Down 5.1%

Shares of NASDAQ AVR opened at $4.98 on Monday. The firm has a market cap of $205.18 million and a price-to-earnings ratio of -2.75. The company’s 50-day simple moving average is $4.46 and its 200-day simple moving average is $4.20. The company has a quick ratio of 0.80, a current ratio of 0.84 and a debt-to-equity ratio of 0.01. Anteris Technologies Global Corp. has a 52-week low of $2.34 and a 52-week high of $8.79.

Anteris Technologies Global (NASDAQ:AVR) last released its quarterly earnings results on Wednesday, November 12th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.57) by ($0.05). Anteris Technologies Global had a negative return on equity of 252.71% and a negative net margin of 3,944.93%.The company had revenue of $0.43 million for the quarter, compared to analyst estimates of $0.74 million. Equities analysts predict that Anteris Technologies Global Corp. will post -2.66 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Anteris Technologies Global in a report on Monday, December 8th. Four investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $16.50.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.